Healthcare -
Biotechnology - NASDAQ - US
$ 21.06
1.1 %
$ 1.03 B
Market Cap
-11.14
P/E
ELVN - ACCOUNTS PAYABLE
Accounts Payable ELVN - Enliven Therapeutics, Inc.
532 K
LAST VALUE
-54.06%
2 YEAR CAGR
-10.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR